FDA Expands Ryzumvi Approval to Include Presbyopia
(MedPage Today) -- People with aging-associated farsightedness gained a new topical treatment option as the FDA expanded the approval of phentolamine ophthalmic solution 0.75% (Ryzumvi) to include presbyopia, according to Opus Genetics and Viatris...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.